UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro

Drug metabolism and disposition, 2005-06, Vol.33 (6), p.764-770

2005

Volltextzugriff (PDF)

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.304-312

2007

Volltextzugriff (PDF)

A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient

The American journal of gastroenterology, 2010-06, Vol.105 (6), p.1231-1238

2010

Volltextzugriff (PDF)

Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

Clinical infectious diseases, 2009-02, Vol.48 (3), p.350-361

2009

Volltextzugriff (PDF)

A Low-Effort, Clinic-Wide Intervention Improves Attendance for HIV Primary Care

Clinical infectious diseases, 2012-10, Vol.55 (8), p.1124-1134

2012

Volltextzugriff (PDF)

Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy

AIDS patient care and STDs, 2011-03, Vol.25 (3), p.153-161

2011

Volltextzugriff (PDF)

HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211

Clinical infectious diseases, 2007-02, Vol.44 (4), p.591-595

2007

Volltextzugriff (PDF)

Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211

The Journal of infectious diseases, 2009-12, Vol.200 (11), p.1724-1728

2009

Volltextzugriff (PDF)

Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV

Journal of acquired immune deficiency syndromes (1999), 2010-03, Vol.53 (3), p.338-347

2010

Volltextzugriff (PDF)

The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV

AIDS patient care and STDs, 2008-04, Vol.22 (4), p.313-321

2008

Volltextzugriff (PDF)

Human Immunodeficiency Virus Infection Alters Tumor Necrosis Factor Alpha Production via Toll-Like Receptor-Dependent Pathways in Alveolar Macrophages and U1 Cells

Journal of Virology, 2008-08, Vol.82 (16), p.7790-7798

2008

Volltextzugriff (PDF)

Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence

AIDS and behavior, 2008, Vol.12 (1), p.86-94

2008

Volltextzugriff (PDF)

Enfuvirtide, a New Fusion Inhibitor for Therapy of Human Immunodeficiency Virus Infection

Pharmacotherapy, 2004-02, Vol.24 (2), p.198-211

2004

Volltextzugriff (PDF)

CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection

Blood, 2001-07, Vol.98 (1), p.156-164

2001

Volltextzugriff (PDF)

Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211

Clinical infectious diseases, 2009-03, Vol.48 (5), p.642-649

2009

Volltextzugriff (PDF)

Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients

Journal of acquired immune deficiency syndromes (1999), 2010-08, Vol.54 (5), p.470-476

2010

Volltextzugriff (PDF)

Acceptance of interferon-gamma release assay by a high-risk urban cohort

The international journal of tuberculosis and lung disease, 2011-10, Vol.15 (10), p.1334-1339

2011

Volltextzugriff (PDF)

The effect of protease inhibitors on weight and body composition in HIV-infected patients

AIDS (London), 1998-09, Vol.12 (13), p.1645-1651

1998

Volltextzugriff (PDF)

Assessing Human Immunodeficiency Virus Type 1 Tropism: Comparison of Assays Using Replication-Competent Virus versus Plasma-Derived Pseudotyped Virions

Journal of Clinical Microbiology, 2009-08, Vol.47 (8), p.2604-2606

2009

Volltextzugriff (PDF)

Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy

AIDS (London), 1999-07, Vol.13 (11), p.1351-1357

1999

Volltextzugriff (PDF)

Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men

American journal of physiology: endocrinology and metabolism, 2002-07, Vol.283 (1), p.E138-E145

2002

Volltextzugriff (PDF)

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection

AIDS patient care and STDs, 2011-03, Vol.25 (3), p.135-141

2011

Volltextzugriff (PDF)

Effective HIV Case Identification Through Routine HIV Screening at Urgent Care Centers in Massachusetts

American journal of public health (1971), 2005-01, Vol.95 (1), p.71-73

2005

Volltextzugriff (PDF)

Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection

Clinical infectious diseases, 2004-06, Vol.38 (12), p.1771-1779

2004

Volltextzugriff (PDF)

HIV Therapy — What Do We Know, and When Do We Know It?

The New England journal of medicine, 2003-12, Vol.349 (24), p.2351-2352

Skolnik, Paul R

2003

Volltextzugriff (PDF)

1 – 25 von 406

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(256)
Mit Volltextzugriff
(313)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(404)
Spanisch
(1)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(198)
Humans
(164)
Life Sciences & Biomedicine
(158)
Biological And Medical Sciences
(82)
Male
(80)
Adult
(76)
Female
(70)
Medical Sciences
(69)
Infectious Diseases
(62)
Middle Aged
(58)
Aids/hiv
(44)
Hiv
(42)
Human Immunodeficiency Virus
(39)
Immunology
(39)
Virology
(31)
Hiv Infections - Drug Therapy
(30)
Human Viral Diseases
(29)
Viral Diseases
(29)
Microbiology
(27)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(27)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Atazanavir: effects on P-glycoprotein transport and CYP3A metabolism in vitro

Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1-Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211

A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient

Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

A Low-Effort, Clinic-Wide Intervention Improves Attendance for HIV Primary Care

Randomized controlled trial of a personalized cellular phone reminder system to enhance adherence to antiretroviral therapy

HIV Type 1 Chemokine Coreceptor Use among Antiretroviral-Experienced Patients Screened for a Clinical Trial of a CCR5 Inhibitor: AIDS Clinical Trial Group A5211

Response to Vicriviroc in Treatment-Experienced Subjects, as Determined by an Enhanced-Sensitivity Coreceptor Tropism Assay: Reanalysis of AIDS Clinical Trials Group A5211

Provider-focused intervention increases adherence-related dialogue but does not improve antiretroviral therapy adherence in persons with HIV

The relationship of post-traumatic stress disorder and depression to antiretroviral medication adherence in persons with HIV

Human Immunodeficiency Virus Infection Alters Tumor Necrosis Factor Alpha Production via Toll-Like Receptor-Dependent Pathways in Alveolar Macrophages and U1 Cells

Optimal Recall Period and Response Task for Self-Reported HIV Medication Adherence

Enfuvirtide, a New Fusion Inhibitor for Therapy of Human Immunodeficiency Virus Infection

CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection

Lymphoma Diagnosis and Plasma Epstein-Barr Virus Load during Vicriviroc Therapy: Results of the AIDS Clinical Trials Group A5211

Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients

Acceptance of interferon-gamma release assay by a high-risk urban cohort

The effect of protease inhibitors on weight and body composition in HIV-infected patients

Assessing Human Immunodeficiency Virus Type 1 Tropism: Comparison of Assays Using Replication-Competent Virus versus Plasma-Derived Pseudotyped Virions

Elevated resting energy expenditure among HIV-seropositive persons receiving highly active antiretroviral therapy

Role of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men

Incidence and predictors of acute kidney injury in an urban cohort of subjects with HIV and hepatitis C virus coinfection

Effective HIV Case Identification Through Routine HIV Screening at Urgent Care Centers in Massachusetts

Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 Infection

HIV Therapy — What Do We Know, and When Do We Know It?

Suchergebnisse filtern